Epitope mapping¶
The evidence-guided identification and resolution of the antigenic site recognized by an antibody, with explicit boundaries among linear, conformational, structural, and functional binding descriptions.
Core Idea¶
Epitope mapping is the evidence-guided determination of which part of an antigen is recognized by a particular antibody or antibody-defined response. The output can range from a broad region to individual residues or a three-dimensional contact surface, and the claimed resolution must match the evidence. Nilvebrant and Rockberg describe mapping as a family of complementary strategies for locating and characterizing antibody-recognition sites rather than as one universal assay. The stable identity is specified binder + specified antigen + evidence about recognition + localized, resolution-qualified site. It is not the antigen itself, not an unverified computational prediction, and not a generic statement that two molecules interact.
Scope of Application¶
Epitope mapping applies to descriptive characterization of antibody-recognition sites. The abstraction spans evidence classes while requiring that each conclusion remain within the resolution and biological context of the underlying observations.
- Antibody characterization. Mapped sites distinguish reagents that bind different regions of one antigen.
- Structural immunology. Contact surfaces can be interpreted in three-dimensional antigen and antibody structures.
- Diagnostic research. Recognition regions help explain assay specificity and cross-reactivity at a conceptual level.
- Vaccine research. Mapped sites can inform hypotheses about immune recognition without establishing efficacy by themselves.
- Escape analysis. Changes associated with reduced binding can be localized and separated from global folding effects.
- Competition grouping. Overlapping recognition can narrow relationships among antibodies while preserving coarse resolution.
- Comparative antigen analysis. Conserved and variable regions can contextualize cross-reactivity.
- Evidence integration. Functional, sequence, competition, and structural observations can jointly constrain a site.
Clarity¶
Name the antibody or binder, antigen form, species or construct context, and coordinate system used for the mapped site. State whether the claim is regional, sequence-level, residue-level, or atomic. Distinguish continuous sequence evidence from a folded discontinuous surface. Distinguish a structural epitope—physical contacts under a resolved complex—from a functional epitope inferred through changes in binding. A residue whose substitution reduces signal may be a contact, may stabilize the antigen, may alter accessibility, or may change presentation; the inference must reflect those alternatives.
Manages Complexity¶
Antibody recognition is distributed across sequence, three-dimensional structure, chemical modification, dynamics, and assay context. Epitope mapping organizes this complexity by separating the target pair, the evidence mode, the localization output, and the resolution claim. Sequence-fragment evidence is informative for some continuous sites; structural evidence can reveal a discontinuous surface; functional perturbation can identify important residues while leaving contact status uncertain; competition can establish neighborhood or overlap without exact coordinates.
Abstract Reasoning¶
- Identify the antibody or binder, antigen form, sequence or structure version, and biological context. 2. State the mapping question and the maximum resolution the evidence class can support. 3. Classify the candidate site as potentially continuous, conformational, or unresolved. 4. Separate direct recognition observations from indirect functional or folding effects. 5. Map evidence onto a declared residue numbering, sequence interval, domain, or structural surface.
Knowledge Transfer¶
The transferable lesson is that localization depends on the evidence channel and its resolution. A map is not a binary answer but a relation among target, coordinate system, evidence, scale, and uncertainty. That lesson transfers to receptor-site mapping and other molecular characterization, while antibody–antigen recognition remains the domain accent. Measurement is the strict parent because epitope mapping turns observations into a site estimate with resolution, conditions, and uncertainty. The child adds recognition-pair identity, antigen coordinates, conformational structure, functional-versus-structural interpretation, and biological context. Removing those roles yields general localization or measurement.
Relationships to Other Abstractions¶
Current abstraction Epitope mapping Domain-specific
Parents (1) — more general patterns this builds on
-
Epitope mapping is a kind of Measurement Prime
Measurement is the narrowest accepted prime because the workflow maps a binding-site attribute to a region or surface through declared evidence, coordinates, resolution, and uncertainty.
Hierarchy path (1) — routes to 1 parentless root
- Epitope mapping → Measurement
Neighborhood in Abstraction Space¶
Epitope mapping sits in a sparse region of the domain-specific corpus (86th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Protein Structure & Antigen Recognition (7 abstractions)
Nearest neighbors
- Antigen — 0.83
- Protein Tag — 0.80
- Immunodiffusion — 0.79
- THEMATICS — 0.79
- Alloprotein — 0.79
Computed from structural-signature embeddings · 2026-09-08